Briefing: Pharmalittle: Trump Drug Pricing Flaw and Gilead Deal Insights
Strategic angle: Comments from a top Trump administration health official highlight significant issues in the president’s drug pricing plans.
Editorial Staff
1 min read
Updated 4 months ago
Major flaw identified in Trump's most-favored nation drug pricing plans.
Insights into a new deal involving Gilead.
Ongoing discussions about drug pricing reforms.